GLENMARK is ready keep am eyesGLENMARK is good stock this is good understanding how market react on good level
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
35.80 INR
10.47 B INR
133.22 B INR
138.37 M
About Glenmark Pharmaceuticals Limited
Sector
Industry
CEO
Glenn Mario Saldanha
Website
Headquarters
Mumbai
Founded
1977
ISIN
INE935A01035
FIGI
BBG000BJ3VG6
Glenmark Pharmaceuticals Ltd. is a holding company, which engages in the development, manufacture, and marketing of pharmaceutical products. It operates through the following geographical segments: India, North America, Europe, Latin America, and Rest of the World. The company was founded by Gracias Saldanha on November 18, 1977 and is headquartered in Mumbai, India.
Related stocks
GLENMARK PHARMA is good to watch and grab for big returnsGLENMARK PHARMA Showing uptrend and it is now in its impulse wave, so soon it will move in upwords direction very fast . so we can grab it below 1788. for the target above 2279. lets wait and watch
Glenmark Pharma: Wave 4 Nearing Its End — Wave 5 Setup in FocusAfter an impulsive five-wave advance from ₹1,275 to ₹2,284, Glenmark Pharmaceuticals appears to be wrapping up a textbook A-B-C correction for Wave 4.
Wave Structure
The drop from ₹2,284.80 subdivides cleanly into A–B–C, with Wave C finding support near the 0.5 retracement (₹1,827).
A rising
Glenmark Pharmaceuticals Ltd for 25th Sept #GLENMARK Glenmark Pharmaceuticals Ltd for 25th Sept #GLENMARK
Resistance 2040 Watching above 2042 for upside momentum.
Support area 2000 Below 2020 gnoring upside momentum for intraday
Watching below 1996 for downside movement...
Above 2020 ignoring downside move for intraday
Charts for Educational purp
Glenmark_LongGlenmark Long:
- Price still below 20 DEMA
- Hidden bullish Div
- Watch for potential Long
Glenmark Pharma – Historic 16-Year Cup & Handle Breakout!Glenmark has completed a massive Cup and Handle pattern after nearly 16 years, breaking past its 2008 all-time high with a powerful volume spike. This is a textbook long-term breakout, potentially signaling the start of a major multi-year bullish trend in the pharma sector.
Amazing breakout on WEEKLY Timeframe - GLENMARKCheckout an amazing breakout happened in the stock in Weekly timeframe, macroscopically seen in Daily timeframe. Having a great favor that the stock might be bullish expecting a staggering returns of minimum 25% TGT. IMPORTANT BREAKOUT LEVELS ARE ALWAYS RESPECTED!
NOTE for learners: Place the break
GLENMARK PHARMACEUTICALS S/RSupport and Resistance Levels:
Support Levels: These are price points (green line/shade) where a downward trend may be halted due to a concentration of buying interest. Imagine them as a safety net where buyers step in, preventing further decline.
Resistance Levels: Conversely, resistance levels (re
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
PHARMABEES
Nippon India Nifty Pharma ETF Units Exchange Traded FundWeight
3.55%
Market value
4.08 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of GLENMARK is 1,881.50 INR — it has increased by 1.85% in the past 24 hours. Watch Glenmark Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Glenmark Pharmaceuticals Limited stocks are traded under the ticker GLENMARK.
GLENMARK stock has fallen by −0.19% compared to the previous week, the month change is a 0.65% rise, over the last year Glenmark Pharmaceuticals Limited has showed a 27.29% increase.
We've gathered analysts' opinions on Glenmark Pharmaceuticals Limited future price: according to them, GLENMARK price has a max estimate of 2,735.00 INR and a min estimate of 1,570.00 INR. Watch GLENMARK chart and read a more detailed Glenmark Pharmaceuticals Limited stock forecast: see what analysts think of Glenmark Pharmaceuticals Limited and suggest that you do with its stocks.
GLENMARK reached its all-time high on Jul 11, 2025 with the price of 2,284.80 INR, and its all-time low was 4.60 INR and was reached on Aug 13, 2001. View more price dynamics on GLENMARK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GLENMARK stock is 3.08% volatile and has beta coefficient of 0.77. Track Glenmark Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is Glenmark Pharmaceuticals Limited there?
Today Glenmark Pharmaceuticals Limited has the market capitalization of 519.55 B, it has increased by 3.38% over the last week.
Yes, you can track Glenmark Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
Glenmark Pharmaceuticals Limited is going to release the next earnings report on Feb 13, 2026. Keep track of upcoming events with our Earnings Calendar.
Glenmark Pharmaceuticals Limited revenue for the last quarter amounts to 60.47 B INR, despite the estimated figure of 37.29 B INR. In the next quarter, revenue is expected to reach 42.74 B INR.
GLENMARK net income for the last quarter is 6.10 B INR, while the quarter before that showed 468.71 M INR of net income which accounts for 1.20 K% change. Track more Glenmark Pharmaceuticals Limited financial stats to get the full picture.
As of Nov 26, 2025, the company has 16.62 K employees. See our rating of the largest employees — is Glenmark Pharmaceuticals Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Glenmark Pharmaceuticals Limited EBITDA is 35.11 B INR, and current EBITDA margin is 17.88%. See more stats in Glenmark Pharmaceuticals Limited financial statements.
Like other stocks, GLENMARK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Glenmark Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Glenmark Pharmaceuticals Limited technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Glenmark Pharmaceuticals Limited stock shows the strong buy signal. See more of Glenmark Pharmaceuticals Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.